Compliance Rate
Compliance Rate
50.0%
Compliant submissions
1
Incompliant submissions
1
Total trials
2
My Organizations' Clinical Trials
Showing 3250 of 3499 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/31/10
End: 08/23/17
Due: 08/23/18
Phase: N/A
Priority: Normal
Start: 04/30/03
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 12/31/10
End: 01/20/16
Due: 01/20/17
Phase: N/A
Priority: Normal
Start: 03/31/98
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 10/31/04
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 04/30/99
End: 09/30/13
Due: 09/30/14
Phase: N/A
Priority: Normal
Start: 08/19/21
End: 11/01/25
Due: 11/01/26
Phase: N/A
Priority: Normal
Start: 05/01/06
End: 10/06/11
Due: 10/06/12
Phase: N/A
Priority: Normal
Start: 05/31/02
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 05/01/95
End: 10/08/20
Due: 10/08/21
Phase: N/A
Priority: Normal
Start: 12/31/10
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 10/31/01
End: 09/30/05
Due: 09/30/06
Phase: N/A
Priority: Normal
Start: 03/12/17
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 06/12/06
End: 03/29/18
Due: 03/29/19
Phase: N/A
Priority: Normal
Start: 05/16/13
End: 06/10/21
Due: 06/10/22
Phase: N/A
Priority: Normal
Start: 04/15/08
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 04/15/10
End: 09/30/18
Due: 09/30/19
Phase: N/A
Priority: Normal
Start: 10/11/11
End: 02/11/17
Due: 02/11/18
Phase: N/A
Priority: Normal
Start: 09/30/04
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 01/31/94
End: 11/30/00
Due: 11/30/01
Phase: N/A
Priority: Normal
Start: 08/01/10
End: 02/19/15
Due: 02/19/16
Phase: N/A
Priority: Normal
Start: 07/24/19
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 09/30/03
End: 06/30/12
Due: 06/30/13
Immunotherapy With E7 T Cell Receptor T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions
Phase: N/A
Priority: Normal
Start: 10/09/19
End: 06/22/20
Due: 06/22/21
Phase: N/A
Priority: Normal
Start: 08/31/02
End: -
Due: -